Terminated PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT00592566

Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

An Open Randomized Controlled Trial of Desmopressin, and Dexamethasone as Adjunctive Therapy in Patients With Pulmonary Hemorrhage Associated With Leptospirosis

Sponsor: Mahidol University

Conditions Leptospirosis

Interventions Dexamethasone, desmopressin

Updated 5 times since 2017 Last updated: Jan 11, 2008 Started: Jul 31, 2003 Primary completion: Oct 31, 2006 Completion: Oct 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Numbe of eligible patients has been decreased over time.

Other terminated trials from Mahidol University

See all terminations from Mahidol University

This PHASE2/PHASE3 trial investigates Leptospirosis and is currently terminated or withdrawn. Mahidol University leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2_PHASE3

First recorded

Jul 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mahidol University
Thailand Research Fund

Data source: Mahidol University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mueng, Thailand